Treatment scale-up to achieve global HCV incidence and mortality elimination targets: a cost-effectiveness model

Grants

Funding Acknowledgements

The authors gratefully acknowledge the contribution to this work through project funding from the Victorian Infectious Diseases Service Special Purpose Fund at Melbourne Health, and support to the Burnet Institute provided by the Victorian Government Operational Infrastructure Support Program. NS is the recipient of a Burnet Institute Jim and Margaret Beever fellowship; MEH, JSD, AT and EMB are the recipients of National Health and Medical Research Council fellowships.